Dermira, Inc. | Business Contracts

First Supplemental Indenture, dated February 20, 2020, between Dermira, Inc. and U.S. Bank National Association (Filed With SEC on February 20, 2020)

Tender and Support Agreement, dated as of January 10, 2020, by and among Eli Lilly and Company, Bald Eagle Acquisition Corporation, New Enterprise Associates 13, L.P. and NEA... (Filed With SEC on January 10, 2020)

Tender and Support Agreement, dated as of January 10, 2020, by and among Eli Lilly and Company, Bald Eagle Acquisition Corporation, Bay City Capital Fund V, L.P., Bay City Capital... (Filed With SEC on January 10, 2020)

Agreement and Plan of Merger by and among Eli Lilly, Bald Eagle Acquisition Corporation and Dermira, Inc., dated January 10, 2020 (Filed With SEC on January 10, 2020)

First Amendment to Credit Agreement dated as of August 5, 2019, by and between the Registrant and Athyrium Opportunities III Acquisition LP (Filed With SEC on November 5, 2019)

First Amendment to License Agreement, dated February 26, 2019, by and between the Registrant and F. Hoffmann-La Roche Ltd and Genentech, Inc (Filed With SEC on May 7, 2019)

Option and License Agreement, dated February 11, 2019, by and between the Registrant and Almirall, S.A (Filed With SEC on May 7, 2019)

Underwriting Agreement dated March 19, 2019 (Filed With SEC on March 20, 2019)

Transition Agreement, dated November 6, 2017, by and between the Registrant and UCB Pharma S.A (Filed With SEC on February 22, 2018)

Offer Letter, accepted and agreed to December 5, 2016, by and between the Registrant and Lori Lyons-Williams (Filed With SEC on February 22, 2018)

DERMIRA, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 16, 2017 3.00% Convertible Senior Notes due 2022 TABLE OF CONTENTS (Filed With SEC on May 16, 2017)

Dermira, Inc. 5,000,000 Shares Common Stock ($0.001 parvalue) Underwriting Agreement (Filed With SEC on March 2, 2017)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 7, 2016)

THIRD AMENDMENT TO LEASE (Filed With SEC on August 8, 2016)

Dermira, Inc. 4,500,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on June 8, 2016)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 4, 2016)

Dermira, Inc. [] Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on August 4, 2015)

* * * * * (Filed With SEC on March 25, 2015)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 25, 2015)

DERMIRA, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on November 12, 2014)

DERMIRA, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on November 12, 2014)

DERMIRA, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on September 19, 2014)

DERMIRA, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 19, 2014)

DERMIRA, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on September 19, 2014)

INDEMNITY AGREEMENT (Filed With SEC on September 19, 2014)

Dermira, Inc. Shares(1) Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on September 19, 2014)

SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on September 12, 2014)

LEASE AGREEMENT (Filed With SEC on September 12, 2014)

DERMIRA, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 12, 2014)

DERMIRA, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on September 12, 2014)

AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on August 27, 2014)

DERMIRA, INC. 2010 EQUITY INCENTIVE PLAN As Adopted on October 15, 2010 and Amended on August 3, 2011, March 22, 2013, July 11, 2013, April 29, 2014 and August 14, 2014 (Filed With SEC on August 27, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 27, 2014)

[Remainder of Page Intentionally Left Blank] (Filed With SEC on August 27, 2014)

BASIC LEASE INFORMATION 2055-2075 Woodside Road (Filed With SEC on August 27, 2014)

Dermira, Inc. (36)